Exclusive

Publication

Byline

Location

US Patent Issued to Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs on Sept. 15 for "Bisphosphonate-linked compounds" (Oregon Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,241, issued on Sept. 15, was assigned to Oregon Health & Science University (Portland, Ore.) and The United States Government as Represente... Read More


US Patent Issued to INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V. V. I. on Sept. 15 for "Carbohydrate derivatives and kits for cell surface labeling" (Null, Czech Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,242, issued on Sept. 15, was assigned to INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY AS CR, V. V. I. (Prague). "Carbohydrate derivativ... Read More


US Patent Issued to NINGBO KUNPENG BIOTECH on Sept. 15 for "Polypeptide derivative and preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,243, issued on Sept. 15, was assigned to NINGBO KUNPENG BIOTECH Co. LTD. (Ningbo, China). "Polypeptide derivative and preparation method t... Read More


US Patent Issued to Mablink Bioscience on Sept. 15 for "Antibody-drug conjugates and their uses" (French Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,244, issued on Sept. 15, was assigned to Mablink Bioscience (Lyons, France). "Antibody-drug conjugates and their uses" was invented by War... Read More


US Patent Issued to Universitat Pompeu Fabra on Sept. 15 for "Treatment and/or diagnosis of a cancer type characterized by expressing zinc transporter ZIP4" (Spanish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,245, issued on Sept. 15, was assigned to Universitat Pompeu Fabra (Barcelona, Spain). "Treatment and/or diagnosis of a cancer type charact... Read More


US Patent Issued to Dyne Therapeutics on Sept. 15 for "Anti-transferrin receptor (TFR) antibody, encoding nucleic acid thereof and method of use thereof to deliver an oligonucleotide to a subject" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,246, issued on Sept. 15, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.). "Anti-transferrin receptor (TFR) antibody, encoding nucl... Read More


US Patent Issued to CASE WESTERN RESERVE UNIVERSITY on Sept. 15 for "Compositions and methods for targeted amplification of coagulation and phagocytosis" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,247, issued on Sept. 15, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland). "Compositions and methods for targeted amplification... Read More


US Patent Issued to TECHNION RESEARCH & DEVELOPMENT FOUNDATION on Sept. 15 for "Composition and method for a prebiotic delivery system targeted to probiotic bacteria" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,248, issued on Sept. 15, was assigned to TECHNION RESEARCH & DEVELOPMENT FOUNDATION Ltd. (Haifa, Israel). "Composition and method for a pr... Read More


US Patent Issued to Generation Bio on Sept. 15 for "Lipids and compositions thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,249, issued on Sept. 15, was assigned to Generation Bio Co. (Cambridge, Mass.). "Lipids and compositions thereof" was invented by Matthew ... Read More


US Patent Issued to University of South Florida on Sept. 15 for "Modified UBE3A gene for a gene therapy approach for Angelman syndrome" (Florida, New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,250, issued on Sept. 15, was assigned to University of South Florida (Tampa, Fla.). "Modified UBE3A gene for a gene therapy approach for A... Read More